VTGN
VistaGen Therapeutics Inc
0.281$
-0.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 50.5% | 34.8% | 74.3% | 179.8% | 85.8% | 68.8% | – | 69.3% | – | 62.4% | 83.7% | 13.3% | – | |
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 30.7% | 100.0% | 37.6% | 100.0% | 86.7% | 84.6% | |
| 1,385.3% | 1,103.0% | 3,769.2% | 9,104.8% | 5,582.0% | 4,831.2% | – | 4,786.1% | 6,168.6% | 4,676.2% | 2,808.6% | 738.9% | 2,160.3% | |
| 1,153.6% | 913.5% | 2,088.2% | 5,436.9% | 2,292.3% | 1,730.3% | – | 1,791.0% | 1,703.9% | 1,812.2% | 886.5% | 265.4% | 716.5% | |
| 2,538.8% | 2,016.4% | 5,857.2% | 14,541.7% | 7,874.3% | 6,561.5% | – | 6,507.8% | 7,872.5% | 6,488.4% | 3,695.1% | 991.0% | 2,868.9% | |
| -2,438.8% | -1,916.4% | -5,757.2% | -14,441.7% | -7,774.3% | -6,461.5% | – | -6,477.0% | -7,772.5% | -6,450.8% | -3,595.1% | -904.3% | -2,784.3% | |
| -2,369.8% | -1,543.5% | -4,825.1% | -12,777.4% | -7,078.7% | -6,020.9% | – | -6,186.5% | -7,526.0% | -6,237.3% | -3,498.3% | -882.8% | -2,702.4% | |
| -50.5% | 372,548.8% | 0.8% | -179.8% | 3.8% | -6,020.9% | – | – | – | – | 1.5% | – | – | |
| -2,369.8% | -1,543.5% | -4,825.8% | -12,777.4% | -7,082.5% | -6,020.9% | – | -6,186.5% | -7,526.0% | -6,237.3% | -3,499.8% | -882.8% | -2,702.6% | |
| -2,319.8% | -1,881.6% | -5,683.1% | -12,597.6% | -6,992.9% | -5,952.1% | – | -6,117.2% | -7,454.3% | -6,174.9% | -3,554.2% | -869.4% | -2,689.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.